Startups channel feed – Endpoints News

Startups channel feed

Big Pharma VC firms put $11M in seed funds behind cancer startup with bold vision

6 years ago

A longtime Laura Shawver fan calls the serial entrepreneur back to the helm of a biotech upstart

6 years ago

Lantern Pharma charts course for IPO with AI platform that shines light on failed cancer drugs

6 years ago

Abundant funding, sparse data: San Francisco startup backs 'real world' model for rare disease drug development

6 years ago

The newest, $86M Third Rock startup chases the tiny biological machines inside of you

6 years ago

Weathering the storm: Another biotech braves Covid-19 in upsized IPO

6 years ago

Another protein degradation biotech emerges, with the promise of a new approach from an old hand

6 years ago

A quiver of arrows for immune disorders: Pandion scores $80M in fresh funding

6 years ago

David Hallal bags another whopper round, looking to recruit more cell and gene therapy upstarts to ElevateBio BaseCamp

6 years ago

Coupling mRNA with tRNA and new delivery tech, MPM and OrbiMed help birth new $80M biotech into a slowed down world

6 years ago

Turn on, tune in: New York biotech scores $15M+ in chemogenetics bet

6 years ago

A key player behind 2 multibillion-dollar biotech M&A deals is back in the startup business

6 years ago

Former Shire execs set up shop to take a shot at 'under the radar' cancer target

6 years ago

Silverback Therapeutics gets $78M boost to 'reconceptualize' antibody-drug conjugates

6 years ago

Hear hear! Ear gene therapy player Akouos draws $105M in fresh capital

6 years ago

Ex nihilo: Takeda leads $100M+ round to fund biotech's sneak attack on tumors, propelling new IL-2, CTLA-4 drugs to clinic

6 years ago

Jim Wilson's gene therapy startup Passage Bio bucks market sentiments, raising upsized $216M IPO

6 years ago

SoftBank's newest, $165M biotech investment looks for infectious traces in the blood

6 years ago

Animal health vet Juergen Horn makes new antibody play for pets, raking $15M in Series A haul

6 years ago

Fresh off $100M round, GV-backed real-world data startup woos Duke researcher as CMO

6 years ago

Drug discovery in HD: Oxford spinoff's mass spectrometry approach scores fresh funding

6 years ago

Corey Goodman marshals $105M mega-round for his CD47 upstart, looking to break new ground in PhII

6 years ago

From mice to dogs, and someday man: George Church's gene therapy cocktail for aging-related diseases

6 years ago

Dutch biotech scores €25M in small molecule bet to tackle lysosomal storage disorders

6 years ago

First page Previous page 53 54 555657 58 59 Next page Last page